Archiv der Pharmazie

Papers
(The H4-Index of Archiv der Pharmazie is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity74
Cover Picture: Arch Pharm (1/2024)60
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors54
Isoxazole‐Based Compounds Targeting the Taxane‐Binding Site of Tubulin50
Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics48
Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways47
GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians40
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives36
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review35
35
Ultra‐Fast UPLC‐MS/MS Method for the Ripretinib Quantification in the HLMs Matrix With Metabolic Stability Assessment: In‐Silico Study for Toxic Alerts and the Metabolic Lability32
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids32
Carboline Hybrids as Potential Multitarget‐Directed Anti‐Alzheimer's Disease Agents: A Comprehensive Analysis of Design Strategies and Structure–Activity Relationships32
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform28
Issue Information: Arch Pharm (1/2026)28
Review on the pharmacological effects and pharmacokinetics of scutellarein26
Tamoxifen‐Based Dimers: Design, Synthesis, Cell Viability Evaluation on Breast Cancer Cells, and Computational Insights26
AI‐Based Prediction of PROTAC‐ and Molecular Glue‐Mediated Ternary Complexes: A Comparative Evaluation of AlphaFold 3 and Boltz‐225
Unraveling the Anticancer Activity of Sunitinib Derivatives Through Modifications in Solvent‐Exposed Regions: Synthesis, In Vitro Evaluation, and Computational Studies25
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers24
Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents24
Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells24
Fabrication of sulfobutylether‐β‐cyclodextrin/glabridin inclusion complex for promoting bioactivities24
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds23
Sustainable RP‐HPLC Method Development for Simultaneous Estimation of Fampridine and Monomethyl Fumarate in Lipid Nanocarriers and Biological Fluids: Application of AQbd Principles23
Structure–Activity Relationship Study on Ligands Activating the Voltage‐Gated Potassium Channel K V 7.123
DCAF16‐Based Covalent Molecular Glues for Targeted Protein Degradation of Histone Deacetylases23
Discovery of xanthone‐based nitric oxide donors targeting biofilm clearance23
Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells23
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease23
Piperlongumine and its derivatives against cancer: A recent update and future prospective23
Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)23
0.3375449180603